175 related articles for article (PubMed ID: 20535562)
1. L-Dopa decarboxylase expression profile in human cancer cells.
Chalatsa I; Nikolouzou E; Fragoulis EG; Vassilacopoulou D
Mol Biol Rep; 2011 Feb; 38(2):1005-11. PubMed ID: 20535562
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel form of the human L-dopa decarboxylase mRNA.
Vassilacopoulou D; Sideris DC; Vassiliou AG; Fragoulis EG
Neurochem Res; 2004 Oct; 29(10):1817-23. PubMed ID: 15532536
[TBL] [Abstract][Full Text] [Related]
3. Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.
Kokkinou I; Nikolouzou E; Hatzimanolis A; Fragoulis EG; Vassilacopoulou D
Blood Cells Mol Dis; 2009; 42(1):92-8. PubMed ID: 19041269
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression analysis of a novel tissue-specific dopa decarboxylase mRNA splicing variant in Bombyx mori.
Tsukioka D; Izumi S; Adachi T
Biosci Biotechnol Biochem; 2017 Mar; 81(3):555-557. PubMed ID: 27869544
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of human placental L-Dopa decarboxylase.
Siaterli MZ; Vassilacopoulou D; Fragoulis EG
Neurochem Res; 2003 Jun; 28(6):797-803. PubMed ID: 12718431
[TBL] [Abstract][Full Text] [Related]
6. Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
Kalantzis ED; Scorilas A; Vassilacopoulou D
Curr Pharm Biotechnol; 2018; 19(13):1087-1096. PubMed ID: 30417785
[TBL] [Abstract][Full Text] [Related]
7. Revised Exon Structure of l-DOPA Decarboxylase (
Artemaki PI; Papatsirou M; Boti MA; Adamopoulos PG; Christodoulou S; Vassilacopoulou D; Scorilas A; Kontos CK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202911
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches.
Adamopoulos PG; Tsiakanikas P; Kontos CK; Panagiotou A; Vassilacopoulou D; Scorilas A
Gene; 2019 Nov; 719():144075. PubMed ID: 31449843
[TBL] [Abstract][Full Text] [Related]
9. cis-regulatory sequences responsible for alternative splicing of the Drosophila dopa decarboxylase gene.
Shen J; Hirsh J
Mol Cell Biol; 1994 Nov; 14(11):7385-93. PubMed ID: 7935452
[TBL] [Abstract][Full Text] [Related]
10. Control of Dopa decarboxylase gene expression by the Broad-Complex during metamorphosis in Drosophila.
Chen L; O'Keefe SL; Hodgetts RB
Mech Dev; 2002 Dec; 119(2):145-56. PubMed ID: 12464428
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing reveals alternative L-DOPA decarboxylase (DDC) splice variants bearing novel exons, in human hepatocellular and lung cancer cells.
Papatsirou M; Adamopoulos PG; Artemaki PI; Georganti VP; Scorilas A; Vassilacopoulou D; Kontos CK
Gene; 2021 Feb; 768():145262. PubMed ID: 33141052
[TBL] [Abstract][Full Text] [Related]
12. Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis.
Chalatsa I; Arvanitis N; Arvanitis D; Tsakou AC; Kalantzis ED; Vassiliou AG; Sideris DC; Frakolaki E; Vassilaki N; Vassilacopoulou D
Biochimie; 2020 Oct; 177():78-86. PubMed ID: 32835737
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristic and physiological role of DOPA-decarboxylase.
Guenter J; Lenartowski R
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1424-1440. PubMed ID: 28100850
[TBL] [Abstract][Full Text] [Related]
14. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.
Kontos CK; Papadopoulos IN; Fragoulis EG; Scorilas A
Br J Cancer; 2010 Apr; 102(9):1384-90. PubMed ID: 20424616
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a dopa decarboxylase cDNA and the induction of its expression by an insect cytokine, growth-blocking peptide in Pseudaletia separata.
Noguchi H; Tsuzuki S; Tanaka K; Matsumoto H; Hiruma K; Hayakawa Y
Insect Biochem Mol Biol; 2003 Feb; 33(2):209-17. PubMed ID: 12535679
[TBL] [Abstract][Full Text] [Related]
16. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
Papadopoulos EI; Fragoulis EG; Scorilas A
Gene; 2015 Jan; 554(2):174-80. PubMed ID: 25445287
[TBL] [Abstract][Full Text] [Related]
17. L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Vassiliou AG; Siaterli MZ; Frakolaki E; Gkogkosi P; Paspaltsis I; Sklaviadis T; Vassilacopoulou D; Vassilaki N
Biochimie; 2019 May; 160():76-87. PubMed ID: 30796964
[TBL] [Abstract][Full Text] [Related]
18. Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances.
Korbakis D; Fragoulis EG; Scorilas A
Anticancer Drugs; 2013 Mar; 24(3):291-9. PubMed ID: 23328075
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
[TBL] [Abstract][Full Text] [Related]
20. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
